Pritaporn Kingkaew,1,* PitsaphunWerayingyong,1 San San Aye,2 Nilar Tin,3 Alaka Singh,4 Phone Myint2 and Yot Teerawattananon1 1Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Nonthaburi, Thailand, 2Department of Health Planning and 3Department of Health,

Phanthipha Wongwai a, Pritaporn Kingkaew b, Somkiat Asawaphureekorn a, Tharatip Kolatat c aDepartment of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40000, Thailand bHealth Intervention and Technology Assessment Program (HITAP), Nonthaburi 11000, Thailand cDepartment of Pa

Thanthima Suwanthawornkul1, Thunyarat Anothaisintawee2*, Abhasnee Sobhonslidsuk3, Ammarin Thakkinstian4, Yot Teerawattananon1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand, 2 Department of Family Medicine, Faculty of Medicine, Ramathibodi

Full text: http://link.springer.com/article/10.1007s40273-015-0360-1

YOT TEERAWATTANANONa, PRITAPORN KINGKAEWa, TANUNYA KOOPITAKKAJORNa,SITAPORN YOUNGKONGa,b,*, NATTHA TRITASAVITc, PATSRI SRISUWANd and SRIPEN TANTIVESSa aHealth Intervention and Technology Assessment Program (HITAP), Nonthaburi, Thailand bDepartment of Pharmacy, Faculty of Pharmacy, Mahidol Universi

Yot Teerawattananon programme leader1, Alia Luz project associate2, Churnrurtai Kanchanachitra director, Mahidol University Global Health 3, Sripen Tantivess senior researcher 1, On behalf of the Prince Mahidol Award Conference secretariat 1Health Intervention and Technology Assessment Program (

CATHERINE PITTa,* ANNA VASSALLa, YOT TEERAWATTANANONb, ULLA K. GRIFFITHSa, LORNA GUINNESSa, AMIAN WALKERc, NICOLA FOSTERd and KARA HANSONa a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK b Health Intervention and Technology Assess

Mark Blecher, National Treasury, South Africa Anban Pillay, National Department of Health, South Africa Walaiporn Patcharanarumol, International Health Policy Program, Ministry of Public Health, Thailand Warisa Panichkriangkrai, International Health Policy Program, Ministry of Public Health

Kalipso Chalkidou , Amanda Glassman , Robert Marten , Jeanette Vega , Yot Teerawattananon , Nattha Tritasavit , Martha Gyansa-Lutterodt , Andreas Seiter Marie Paule Kieny , Karen Hofmani , Anthony J Culyerj Abstract Governments in low- and middle-income countries are legitimizing the imp

Katharina Kieslich1,*, Jesse B. Bump2 , Ole Frithjof Norheim3 , Sripen Tantivess4 and Peter Littlejohns1 1 Faculty of Life Sciences & Medicine, Division of Health and Social Care Research, King’s College London, London, UK 2 Department of Global Health and Population, Harvard T. H. Chan School o